Abstract:The Hippo pathway plays an evolutionarily conserved fundamental role in controlling organ size in multicellular organisms. Importantly, evidence from studies of patient samples and mouse models clearly indicates that deregulation of the Hippo signaling pathway plays a crucial role in the initiation and progression of many different types of human cancers. The Hippo signaling pathway is regulated by various stimuli, such as mechanical stress, G-protein coupled receptor signaling, and cellular energy status. When activated, the Hippo kinase cascade phosphorylates and inhibits the transcription co-activator YAP (Yes-associated protein), and its paralog TAZ (transcriptional coactivator with PDZ-binding motif), resulting in their cytoplasmic retention and degradation. When the Hippo signaling pathway is inactive, dephosphorylated YAP/TAZ translocate into the nucleus and activate gene transcription through binding to TEAD (TEA domain) family and other transcription factors. Such changes in gene expression promote cell proliferation and stem cell/progenitor cell self-renewal but inhibit apoptosis, thereby coordinately promote increase in organ size, tissue regeneration, and tumorigenesis. In this review, we summarize the molecular mechanisms of the mammalian Hippo signaling pathway with special emphasis on the Hippo kinase cascade and its upstream signals, the Hippo signaling pathway regulation of YAP and the mechanisms of YAP in regulation of gene transcription.

Correction: The Hippo signalling pathway and its implications in human health and diseases

Correction to: Cryptotanshinone activates AMPK-TSC2 axis leading to inhibition of mTORC1 signaling in cancer cells

Hippo signaling pathway in lung development, regeneration, and diseases.

The Hippo signalling pathway and its impact on eye diseases

Correction To: Signaling pathways in obesity: mechanisms and therapeutic interventions

Hippo Signaling in the Immune System.

The Hippo-YAP Pathway in Organ Size Control and Tumorigenesis: an Updated Version.

The Hippo Pathway in Biological Control and Cancer Development

Corrigendum to “Lipopolysaccharide-Induced Podocyte Injury is Regulated by Calcineurin/nfat and TLR4/MyD88/NF-κB Signaling Pathways Through Angiopoietin-like Protein 4” [genes & Diseases 9(2022) 443–455]

Regulation and Functions of the Hippo Pathway in Stemness and Differentiation.

Targeting the Hippo pathway in cancer, fibrosis, wound healing and regenerative medicine

The Role and Regulatory Mechanism of Hippo Signaling Components in the Neuronal System

The Hippo signaling pathway in development and regeneration

Molecular mechanisms of the mammalian Hippo signaling pathway.

The Hippo pathway in organ size control, tissue regeneration and stem cell self-renewal

The Key Protein Machineries in Regulating Liver De-velopment, Regeneration and Size Control

The Hippo signaling pathway: from multiple signals to the hallmarks of cancers

The Hippo pathway in oral diseases and treatments: A review

Structural Dissection of Hippo Signaling

The Hippo pathway in tissue homeostasis and regeneration

The Hippo-YAP pathway: new connections between regulation of organ size and cancer.